Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 MISSION Therapeutics Names CBO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

MISSION Therapeutics Names CBO

Wallace brings 20 years of business development experience

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Paul Wallace Ph.D. has been appointed chief business officer at MISSION Therapeutics. Dr. Wallace will be responsible for the future business strategy for the company’s pipeline, exploring strategic options such as development partnerships.
 
Dr. Wallace has 20 years of business development experience and most recently served as executive vice president and head of business development at Medivir AB, and was a member of the executive management team. He was responsible for strategic and operational leadership, R&D portfolio management and investment planning. 
 
Anker Lundemose, MISSION chief executive officer, said, “With MISSION currently embarking on the preclinical development of its lead molecules, Paul’s extensive business development experience will be invaluable in helping us find the right strategic partnerships to fully realize the potential of these assets. Our core focus is cancer, but our platform discovery approach has yielded highly promising molecules for other indications, such as Parkinson’s disease. We see partnering as an attractive option for taking these non-core projects forward.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics